http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105106199-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4423185f79003e8f9b981e29323454a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-397
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-501
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4523
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-397
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4192
filingDate 2007-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17010087617e259300a443272f1004f1
publicationDate 2015-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105106199-A
titleOfInvention Methods of Using MEK Inhibitors
abstract The present invention provides methods of treating cancer by administering a compound of formula I, or a pharmaceutically acceptable salt or solvate thereof, in combination with other cancer treatments.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103804364-A
priorityDate 2006-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9901421-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006194848-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006045514-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163895375
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419828920
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466337179
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465900165
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163539363
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409520932
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466373884
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409867706
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59469011
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466676720
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465125513
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466006330
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146921715
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58804075
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164074162
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466566869
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16222818
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424269014
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419592657
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467847143
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16222096
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59469004
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421498265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424028705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465168628
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16222605
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146823388
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID59469094
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163569707
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16222302
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407350893
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465638247
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466535779
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407153707
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419828582

Total number of triples: 72.